Service provision for patients with ALS/MND: A cost-effective multidisciplinary approach-Reference-Cited by-同舟云学术

Service provision for patients with ALS/MND: A cost-effective multidisciplinary approach

Published:1998-10 Issue: Volume:160 Page:S141-S145
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Corr B,Frost E,Traynor B.J,Hardiman O

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference12 articles.

1. Management of ALS;Bouche;Rev Neurol,1989

2. Home mechanical ventilation for ALS: nasal compared to tracheostomy-intermittent positive pressure ventilation;Cazolli;J Neurol Sci,1996

3. Chancellor et al, the Scottish motor neurone disease research group. The Scottish motor neurone disease register: A prospective study of adult onset motor neurone disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992;55:536–41.

4. Drugs and Therapeutics Bulletin 1997;35(2):11–21.

5. Friend E, Currie R, Ferguson G, Henderson S, Kamal A, van Teijinnnngen E. Service use and needs of people with MND and their carers in Scotland. Proceedings of the Eighth International Symposium on ALS/MND. 1997:66.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The economic evaluation of ALS care: quality and cost;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-02-16

2. Multidisciplinary clinic contributes to the decreasing trend in the number of emergency hospitalizations for amyotrophic lateral sclerosis in Japan;Journal of Clinical Neuroscience;2023-01

3. Amyotrophic lateral sclerosis (ALS) health charities are central to ALS care: perspectives of Canadians affected by ALS;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2022-09-16

4. Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2022-02-22

5. Patient-centered decision making in amyotrophic lateral sclerosis: where are we?;Neurodegenerative Disease Management;2017-12